The recent rise of generative Artificial Intelligence (AI) has revolutionized the approach to innovative solutions for the Life Sciences industry. ChatGPT (GPT-4), an advanced large language model powered by AI, may have the ability to greatly benefit the pharmaceutical industry. With its ability to understand and generate human-like text, the industry may one day be able to leverage ChatGPT to streamline operations, enhance R&D efforts, improve customer support, and aid in regulatory compliance.
